About 1,591,109 results (5,463 milliseconds)
Ethnobotany/ethnopharmacology and mass bioprospecting: Issues ...
https://groups.google.com/group/kiucamresearch/attach/ad6a20b5daa6e7db/Ethnobotany_ethnopharmacology%20and%20mass%20bioprospecting%20Issues%20on.pdf?part=0.2 Jul 1, 2005 ... Cancer Treatment and Diagnosis (DCT). This ... The paper appears in print form in the publication—Investing in Biological Diversity:.
US20020055092A1 - Methods and systems for assessing biological ...
https://patents.google.com/patent/US20020055092A1/en ... form for display as an image. Alternatively, data may be acquired, processed ... full dynamic range, as described below. Nonuniformity of illumination ...
López-Fernández Lab - Publications
https://sites.google.com/site/hlffishes/publications Organismal form constrains the evolution of complex lever systems in ... PLoS Biology 21(11): e3002318 doi.org/10.1371/journal.pbio.3002318. 68. Turner ...
US7943656B2 - Crystal forms of saxagliptin and processes for ...
https://patents.google.com/patent/US7943656B2/en ... full matrix least-squares. The function minimized in the refinements was ... Biology, vol. 61, John Wiley & Sons, Inc., publ., Meister, A., ed., pp. 201 ...
US20050142573A1 - Gene segregation and biological sample ...
https://patents.google.com/patent/US20050142573A1/en The HG-U95Av2 Array represents approximately 10,000 full-length genes. ... form of lung cancer and is further classified as adenocarcinoma (most common ...
CA2765889A1 - Treatment of tumor necrosis factor receptor 2 (tnfr2 ...
https://patents.google.com/patent/CA2765889A1/en C12N15/11 DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity ... full understanding of the invention. One ...
WO2009158620A2 - Signatures and determinants associated with ...
https://patents.google.com/patent/WO2009158620A2/en ... Dct by RT-PCR using gene-specific primers. XB2, mouse keratinocyte cell ... meaning of the underlying biology. 1000132] One or more, preferably two or ...
US8637257B2 - Molecular targets and compounds, and methods to ...
https://patents.google.com/patent/US8637257B2/en ... form, for example, in a form able to affect a biological activity. For ... No. demand, Ct, DCt(*), Ct, DCt(*), in RASFs. KLKB1, 25, NM_000892, Hs00168478_m1 ...
WO2004025258A2 - Gene segregation and biological sample ...
https://patents.google.com/patent/WO2004025258A2/en The HG-U95Av2 Array represents approximately 10,000 full-length genes. ... form of lung cancer and is further classified as adenocarcinoma (most common ...
US20190367964A1 - Dissociation of human tumor to single cell ...
https://patents.google.com/patent/US20190367964A1/en ... form the tissue sample. ... However, the invention also comprises polypeptides and nucleic acid fragments, so long as they exhibit the desired biological activity ...
US9222088B2 - Treatment of alpha-L-iduronidase (IDUA) related ...
https://patents.google.com/patent/US9222088B2/en C12N15/11 DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity ... full understanding of the invention. One ...
AU2020265250A1 - Frataxin-sensitive markers for determining ...
https://patents.google.com/patent/AU2020265250A1/en (eds.), Springer Verlag (1991); and Hale & Marham, the Harper Collins Dictionary of Biology (1991). ... full-length FXN, via a linker to form a single polypeptide ...
US20170196973A1 - Oncostatin m (osm) antagonists for preventing ...
https://patents.google.com/patent/US20170196973A1/en ... form of OSM, 209 amino acids length having two N-linked glycosylation sites ... long as they exhibit the desired biological activity. [0073]. The term ...
US8673268B2 - Molecular targets and compounds, and methods to ...
https://patents.google.com/patent/US8673268B2/en ... form, for example, in a form able to effect a biological activity. For ... * Expression in primary RASFs: Genes with DCt <13 are considered expressed ...
WO2015094992A1 - Ifn-gamma gene signature biomarkers of tumor ...
https://patents.google.com/patent/WO2015094992A1/en As used herein, the term "antibody" refers to any form of antibody that exhibits the desired biological or binding activity. ... long as they exhibit the desired ...
US8987225B2 - Treatment of NANOG related diseases by inhibition ...
https://patents.google.com/patent/US8987225B2/en C12N15/11 DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity ... full understanding of the invention. One ...
WO2020002694A1 - Microrna targeting agent for treatment of heart ...
https://patents.google.com/patent/WO2020002694A1/en The term gapmer is used in its meaning known in the field of molecular biology and refers to an antisense oligonucleotide complementary to its target ...
US9260471B2 - RNA interference mediated inhibition of gene ...
https://patents.google.com/patent/US9260471B2/en The term also includes reconstituted material from a biological source. The phrase “blunt end” as used herein refers to its meaning as is generally accepted in ...
US5856103A - Method for selectively ranking sequences for ...
https://patents.google.com/patent/US5856103A/en C12N15/11 DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity ... (dCT) = 2 × f(4) - 2 × f(13) + 2 × f(8) F ...
EP0095049A2 - Treatment of obnoxious chemical wastes - Google ...
https://patents.google.com/patent/EP0095049A2/en About 230 species have been reported in activated sludge with ciliates constituting the dominant form. ... (DCT)-2 deposited with the American Type Culture ...